![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Alexion Global Site
As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases.
About Us | Alexion Global Site
As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases. Our Mission To transform the lives of people affected by rare diseases and …
Our Approach | Alexion Global Site
Alexion’s rich history of scientific firsts has accelerated the course of rare disease R&D and changed the trajectory of treatment for people living with certain rare conditions.
Our Medicines | Alexion Global Site
This website is intended for people seeking information on Alexion, AstraZeneca Rare Disease’s worldwide business. Veeva ID: GL/ALL/0071 Date of preparation: January 2025 About Alexion
Rare Disease Research & Development | Alexion Global Site
This website is intended for people seeking information on Alexion, AstraZeneca Rare Disease’s worldwide business. Veeva ID: GL/ALL/0071 Date of preparation: January 2025
Working at Alexion
Alexion has more than 5,000 employees around the globe and serves patients in more than 50 countries. There are limitless opportunities for talented individuals to work across functions …
Spain | Alexion Global Site
At Alexion, our mission is to transform the lives of people with rare diseases through the development and delivery of innovative medicines, as well as support technologies and …
Alexion News Centre | Alexion Global Site - Alexion …
Feb 6, 2024 · Getting to know Adrian Kielhorn, an Alexion R&D Leading Voice. Alexion’s leadership in rare disease is driven by the many individuals whose expertise, creativity and …
Sweden | Alexion Global Site
At Alexion, our mission is to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, as well as supportive technologies and …
Living with Rare Disease | Alexion Global Site
This website is intended for people seeking information on Alexion, AstraZeneca Rare Disease’s worldwide business. Veeva ID: GL/ALL/0071 Date of preparation: January 2025